Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate
Source: scienceblog.com
Page 16 - Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Randomized Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Randomized Trial Today - Breaking & Trending Today
UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.
Source: news-medical.net
Essentia Health joins nationwide study to test medications for COVID-19
Study focuses on medicines that are already on the market for other illnesses.
Source: pineandlakes.com
Where mental health help is scarce, telehealth makes big difference
Large randomized study of two approaches to support rural primary care providers in caring for people with PTSD or bipolar disorder shows both work
Source: miragenews.com
Essentia joins nationwide study to test medications for COVID-19 use
Essentia Health serves as a clinical research site supporting ACTIV-6 by referring eligible study participants. It will enroll and monitor patients’ progress throughout the study’s 90-day follow-up period and will assist them with any questions or concerns that arise.
Source: brainerddispatch.com